Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
RedHill Biopharma Initiates Phase 3 Study of RHB-204 for First-Line Treatment of NTM Disease 2020-11-20 21:00
INOVIO Presents Clinical Results of its DNA Medicines INO-5401 + INO-9012 in Novel Combination with PD-1 Inhibitor Libtayo® (cemiplimab) in the Treatment of Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 2020 Annual Meeting 2020-11-20 21:00
Ortho's CE-Marked VITROS® SARS-CoV-2 Antigen Test Detects Asymptomatic COVID-19 Individuals 2020-11-20 20:00
WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou 2020-11-20 16:30
Zuellig Pharma expands cold storage warehouse capacity across key markets in Asia in preparation for COVID-19 vaccine 2020-11-20 15:31
Qiming's Portfolio Company Antengene Lists on Main Board of HKEX 2020-11-20 14:22
Mopec Adds International Distribution Capabilities in 14 Countries and Regions 2020-11-20 13:59
RedHill Biopharma's Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease 2020-11-20 07:00
Covis Group Announces Data for Ciraparantag Published in Blood, the Journal of the American Society of Hematology 2020-11-20 01:26
LimaCorporate Announces FDA Approval for an Ide Study on Smr Stemless Reverse Shoulder System 2020-11-19 23:00
endpoint and McCreadie Group Software Integration Reduces Drug Speed to Market and Streamlines Research Pharmacy Workflows 2020-11-19 22:00
RedHill Announces Unanimous DSMB Recommendation to Continue Phase 2/3 COVID-19 Study with Opaganib 2020-11-19 20:21
CUHK Microbiome Immunity Formula Hastens Recovery of COVID-19 Patients and Offers Hope to Boost Immunity 2020-11-19 17:13
With Elekta Studio, Elekta brings complete image-guided brachytherapy workflow to a single room 2020-11-19 15:16
ASC40 (TVB-2640) Phase 2 NASH Trial Completed Patient Enrollment in China 2020-11-19 08:30
INEX Innovate's iGene Laboratory announces new personalised medicine genotyping analysis project with Eli Lilly and Company's research unit Lilly Centre for Clinical Pharmacology 2020-11-19 08:00
RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib - Data Expected in the Coming Weeks 2020-11-19 07:00
Mibelle Biochemistry's Ability to Introduce Breakthrough Active Ingredients for the Personal Care Market Lauded by Frost & Sullivan 2020-11-18 23:40
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2021 Financial Results 2020-11-18 20:00
HistoIndex's AI-Based Platform Demonstrates Zonal Quantification and Histological Characterization of Fibrosis Improvements in Patients With Nonalcoholic Steatohepatitis (NASH) 2020-11-18 20:00
1 327 328 329 330 331 531